Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China flag China · Delayed Price · Currency is CNY
56.44
-1.81 (-3.11%)
May 6, 2026, 3:00 PM CST

Xiamen Amoytop Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
23,03834,15729,84721,29615,83711,911
Market Cap Growth
-27.62%14.44%40.15%34.47%32.96%-14.13%
Enterprise Value
22,13833,47329,27220,67015,36011,446
Last Close Price
56.4483.6872.7651.5438.1328.57
PE Ratio
22.8833.1236.0638.3455.1865.73
Forward PE
18.0528.1228.1228.1228.1228.12
PS Ratio
6.039.2410.6010.1410.3710.52
PB Ratio
6.359.9011.6911.3511.2510.26
P/TBV Ratio
7.1511.2912.5312.6412.3211.74
P/FCF Ratio
59.7372.18166.4895.23109.98271.61
P/OCF Ratio
35.0646.8369.3141.5943.6150.73
EV/Sales Ratio
5.809.0610.399.8410.0610.11
EV/EBITDA Ratio
16.6825.2229.2928.9838.0943.97
EV/EBIT Ratio
18.5527.5831.4631.3242.6651.64
EV/FCF Ratio
57.4070.73163.2892.42106.67260.99
Debt / Equity Ratio
0.050.050.000.000.010.02
Debt / EBITDA Ratio
0.140.130.010.010.020.10
Debt / FCF Ratio
0.480.370.050.040.070.57
Net Debt / Equity Ratio
-0.25-0.24-0.26-0.35-0.40-0.39
Net Debt / EBITDA Ratio
-0.68-0.63-0.65-0.93-1.39-1.75
Net Debt / FCF Ratio
-2.33-1.77-3.64-2.96-3.90-10.41
Asset Turnover
1.001.001.041.020.960.87
Inventory Turnover
0.830.770.820.891.391.18
Quick Ratio
3.923.233.552.803.044.01
Current Ratio
4.793.864.343.323.574.71
Return on Equity (ROE)
31.78%34.36%37.37%33.83%22.35%16.77%
Return on Assets (ROA)
19.52%20.43%21.51%19.99%14.09%10.59%
Return on Invested Capital (ROIC)
39.56%47.22%53.10%55.56%37.47%29.64%
Return on Capital Employed (ROCE)
30.70%33.10%35.40%33.80%24.00%17.80%
Earnings Yield
4.40%3.02%2.77%2.61%1.81%1.52%
FCF Yield
1.67%1.39%0.60%1.05%0.91%0.37%
Dividend Yield
1.06%0.74%0.85%0.80%0.56%0.35%
Payout Ratio
24.99%24.52%20.15%15.60%14.17%11.41%
Buyback Yield / Dilution
-0.64%-0.38%-0.56%-0.29%-0.39%-0.18%
Total Shareholder Return
0.43%0.36%0.30%0.50%0.17%0.18%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.